search
Back to results

Integrating Pediatric TB Services Into Child Healthcare Services in Africa (INPUT)

Primary Purpose

Tuberculosis, Children, Only, Diagnosis

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Integrated pediatric TB services
Sponsored by
Elizabeth Glaser Pediatric AIDS Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Tuberculosis

Eligibility Criteria

undefined - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children < 5 years old.
  • TB diagnosis investigations initiated.
  • Other infectious diseases are not suspected or have already been ruled out.
  • Commitment to take treatment in the clinic of enrolment or another INPUT study site.
  • Parental/caregiver consent for the child to participate in the study.

Exclusion Criteria:

  • Children who are TB contacts but without symptoms or signs of active TB

Sites / Locations

  • Hopital de District Akonolinga
  • Hopital de District Soa
  • Hopital de District Loum
  • Hopital de District Foumban
  • Hopital de District Dschang
  • Hopital de District Mbouda
  • Kendu Sub County Hospital
  • Ndhiwa Sub county Hospital
  • Kakuma Mission Hospital
  • Lokitaung sub-county hospital
  • Lopiding Sub County Hospital
  • Homa Bay County Referral Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Standard-of-Care

Intervention

Arm Description

Pediatric TB services based on current routine approach (national standard of care)

Integrated pediatric TB services

Outcomes

Primary Outcome Measures

Proportion of children diagnosed with active TB
Number of pediatric TB cases diagnosed (bacteriologically confirmed and/or clinically diagnosed) over the number of children attending the child healthcare services during the study period.

Secondary Outcome Measures

Proportion of children screened for TB
Number of children screened for TB over the number of children attending the child healthcare services during the study period
Proportion of screened children who have a sample collected
Proportion of children who have a sample collected for microbiologic diagnosis among those screened positive for TB (i.e. presumptive TB cases)
Proportion of children diagnosed with TB among presumptive TB cases
Proportion of children diagnosed with TB (bacteriologically or clinically) among presumptive TB cases, overall and disaggregated by HIV status and nutrition status
Time from screening to clinical or bacteriologic diagnosis
For children finally diagnosed with TB, time elapsed from presumptive to confirmed TB case
Time from diagnosis to treatment initiation
For children diagnosed with TB, time elapsed to initiate treatment after active TB is confirmed
Proportion of cases with a bacteriologically confirmed diagnosis
Proportion of cases with a bacteriologically confirmed diagnosis among children diagnosed with TB
Proportion of children who initiate TB treatment among those diagnosed
Proportion of children who initiate TB treatment among those diagnosed will give treatment coverage
Treatment outcome
Treatment outcomes for patients initiated on treatment according to WHO categories: treatment success, treatment failed, died, lost to follow-up, and not evaluated.
Adherence to the TB treatment
Adherence documented by seven-day recall and counting of pills

Full Information

First Posted
February 12, 2019
Last Updated
March 22, 2022
Sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Collaborators
UNITAID, University of Sheffield, Kenya Ministry of Health, Cameroon Ministry of Public Health
search

1. Study Identification

Unique Protocol Identification Number
NCT03862261
Brief Title
Integrating Pediatric TB Services Into Child Healthcare Services in Africa
Acronym
INPUT
Official Title
Integrating Pediatric TB Services Into Child Healthcare Services in Africa. A Cluster-randomized Stepped-wedge Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
May 10, 2019 (Actual)
Primary Completion Date
June 30, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Collaborators
UNITAID, University of Sheffield, Kenya Ministry of Health, Cameroon Ministry of Public Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Under-diagnosis of TB in children is a critical gap to address. The INPUT study is a multinational stepped-wedge cluster-randomized intervention study aiming to assess the effect of integrating TB services into child healthcare services on TB diagnosis capacities in children under 5 years of age.
Detailed Description
Study clusters (district-level hospitals and their health centers) will start under standard-of-care and transition to the intervention at randomly assigned time points. In this study two strategies will be compared: i) The standard of care, offering pediatric TB services based on current routine approach; ii) The intervention, with pediatric TB services integrated into child healthcare services. The primary objective will be to assess the effect of the intervention compared to standard of care on the proportion of TB cases diagnosed among children <5 years old (that is the number of children who are clinically or bacteriologically diagnosed with TB over the total number of children attending the child healthcare services). Secondary objectives are detailed in the protocol. Study sites will include six hospital in each participating country (Cameroon and Kenya) along with selected attached health centers. The study population will be children aged less than five years of age with a presumptive diagnosis of TB. Study enrollment will start in March 2019, last enrollments until July 2020 and follow up will be completed by August 2021.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tuberculosis, Children, Only, Diagnosis, Delivery of Health Care

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Cluster-randomized stepped-wedge model, where intervention will be randomly allocated to the different study sites at different time points.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1715 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard-of-Care
Arm Type
No Intervention
Arm Description
Pediatric TB services based on current routine approach (national standard of care)
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Integrated pediatric TB services
Intervention Type
Other
Intervention Name(s)
Integrated pediatric TB services
Intervention Description
pediatric TB services will be integrated into key child healthcare services: maternal neonatal and child health (MNCH) services, under-5 clinic, pediatric outpatient services, nutrition services, pediatric antiretroviral therapy (ART) services and primary health care: Integration of the screening into all the child health care services with introduction of a specific case detection tool and updated presumptive TB register. Improvement of diagnosis capacities and their integration in all levels of care and all services.
Primary Outcome Measure Information:
Title
Proportion of children diagnosed with active TB
Description
Number of pediatric TB cases diagnosed (bacteriologically confirmed and/or clinically diagnosed) over the number of children attending the child healthcare services during the study period.
Time Frame
up to two months
Secondary Outcome Measure Information:
Title
Proportion of children screened for TB
Description
Number of children screened for TB over the number of children attending the child healthcare services during the study period
Time Frame
one month
Title
Proportion of screened children who have a sample collected
Description
Proportion of children who have a sample collected for microbiologic diagnosis among those screened positive for TB (i.e. presumptive TB cases)
Time Frame
up to three months
Title
Proportion of children diagnosed with TB among presumptive TB cases
Description
Proportion of children diagnosed with TB (bacteriologically or clinically) among presumptive TB cases, overall and disaggregated by HIV status and nutrition status
Time Frame
up to two months
Title
Time from screening to clinical or bacteriologic diagnosis
Description
For children finally diagnosed with TB, time elapsed from presumptive to confirmed TB case
Time Frame
up to three months
Title
Time from diagnosis to treatment initiation
Description
For children diagnosed with TB, time elapsed to initiate treatment after active TB is confirmed
Time Frame
up to three months
Title
Proportion of cases with a bacteriologically confirmed diagnosis
Description
Proportion of cases with a bacteriologically confirmed diagnosis among children diagnosed with TB
Time Frame
up to three months
Title
Proportion of children who initiate TB treatment among those diagnosed
Description
Proportion of children who initiate TB treatment among those diagnosed will give treatment coverage
Time Frame
up to two months
Title
Treatment outcome
Description
Treatment outcomes for patients initiated on treatment according to WHO categories: treatment success, treatment failed, died, lost to follow-up, and not evaluated.
Time Frame
8 to 14 months (2 months after treatment completion)
Title
Adherence to the TB treatment
Description
Adherence documented by seven-day recall and counting of pills
Time Frame
6 to 12 months (at treatment completion)

10. Eligibility

Sex
All
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children < 5 years old. TB diagnosis investigations initiated. Other infectious diseases are not suspected or have already been ruled out. Commitment to take treatment in the clinic of enrolment or another INPUT study site. Parental/caregiver consent for the child to participate in the study. Exclusion Criteria: Children who are TB contacts but without symptoms or signs of active TB
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Appolinaire Tiam, MBChB, MMed
Organizational Affiliation
Elizabeth Glaser Pediatric AIDS Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital de District Akonolinga
City
Akonolinga
State/Province
Centre
Country
Cameroon
Facility Name
Hopital de District Soa
City
Soa
State/Province
Centre
Country
Cameroon
Facility Name
Hopital de District Loum
City
Loum
State/Province
Littoral
Country
Cameroon
Facility Name
Hopital de District Foumban
City
Mbanga
State/Province
Littoral
Country
Cameroon
Facility Name
Hopital de District Dschang
City
Dschang
State/Province
West
Country
Cameroon
Facility Name
Hopital de District Mbouda
City
Mbouda
State/Province
West
Country
Cameroon
Facility Name
Kendu Sub County Hospital
City
Kendu Bay
State/Province
Homa Bay
Country
Kenya
Facility Name
Ndhiwa Sub county Hospital
City
Ndhiwa
State/Province
Homa Bay
Country
Kenya
Facility Name
Kakuma Mission Hospital
City
Kakuma
State/Province
Turkana
Country
Kenya
Facility Name
Lokitaung sub-county hospital
City
Lokitaung
State/Province
Turkana
Country
Kenya
Facility Name
Lopiding Sub County Hospital
City
Lopiding
State/Province
Turkana
Country
Kenya
Facility Name
Homa Bay County Referral Hospital
City
Homa Bay
Country
Kenya

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
32375741
Citation
Denoeud-Ndam L, Otieno-Masaba R, Tchounga B, Machekano R, Simo L, Mboya JP, Kose J, Tchendjou P, Bissek AZ, Okomo GO, Casenghi M, Cohn J, Tiam A; INPUT Study Group. Integrating pediatric TB services into child healthcare services in Africa: study protocol for the INPUT cluster-randomized stepped wedge trial. BMC Public Health. 2020 May 6;20(1):623. doi: 10.1186/s12889-020-08741-2.
Results Reference
derived

Learn more about this trial

Integrating Pediatric TB Services Into Child Healthcare Services in Africa

We'll reach out to this number within 24 hrs